Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Colwell, JA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 33 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Colwell, JA
      Treatment for the procoagulant state in type 2 diabetes

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    2. Colwell, JA
      Aspirin therapy in diabetes is underutilized

      DIABETES CARE
    3. Olson, JW; Shernoff, AF; Tarlow, JL; Colwell, JA; Scheetz, JP; Bingham, SF
      Dental endosseous implant assessments in a type 2 diabetic population: A prospective study

      INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
    4. Pitale, SU; Abraira, C; Emanuele, NV; McCarren, M; Henderson, WG; Pacold, I; Bushnell, D; Colwell, JA; Nuttall, FQ; Levin, SR; Sawin, CT; Comstock, JP; Silbert, CK
      Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM)

      DIABETES CARE
    5. Levin, SR; Coburn, JW; Abraira, C; Henderson, WG; Colwell, JA; Emanuele, NV; Nuttall, FQ; Sawin, CT; Comstock, JP; Silbert, CK
      Effect of intensive glycemic control on microalbuminuria in type 2 diabetes

      DIABETES CARE
    6. Colwell, JA
      Aspirin therapy in diabetes

      DIABETES CARE
    7. Colwell, JA
      Inflammation and diabetic vascular complications

      DIABETES CARE
    8. Colwell, JA
      Aspirin and risk of hemorrhagic stroke

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    9. AGRAWAL L; EMANUELE NV; ABRAIRA C; HENDERSON WG; LEVIN SR; SAWIN CT; SILBERT CK; NUTTALL FQ; COMSTOCK JP; COLWELL JA
      ETHNIC-DIFFERENCES IN THE GLYCEMIC RESPONSE TO EXOGENOUS INSULIN-TREATMENT IN THE VETERANS AFFAIRS COOPERATIVE STUDY IN TYPE-2 DIABETES-MELLITUS (VA CSDM)

      Diabetes care
    10. ABRAIRA C; HENDERSON WG; COLWELL JA; NUTTALL FQ; COMSTOCK JP; EMANUELE NV; LEVIN SR; SAWIN CT; SILBERT CK
      RESPONSE TO INTENSIVE THERAPY STEPS AND TO GLIPIZIDE DOSE IN COMBINATION WITH INSULIN IN TYPE-2 DIABETES - VA FEASIBILITY STUDY ON GLYCEMICCONTROL AND COMPLICATIONS (VA CSDM)

      Diabetes care
    11. ABRAIRA C; COLWELL JA; NUTTALL F; EMANUELE N; COMSTOCK J; LEVIN S; SAWIN C; SILBERT C
      A CRITICAL ISSUE - INTENSIVE INSULIN-TREATMENT AND MACROVASCULAR DISEASE

      Diabetes care
    12. COLWELL JA
      INSULIN-TREATMENT FOR TYPE-2 DIABETES - REPLY

      JAMA, the journal of the American Medical Association
    13. JOKL R; COLWELL JA
      ARTERIAL THROMBOSIS AND ATHEROSCLEROSIS IN DIABETES

      Diabetes reviews
    14. COLWELL JA
      ELEVATED PLASMA HOMOCYSTEINE AND DIABETIC VASCULAR-DISEASE

      Diabetes care
    15. COLWELL JA
      ASPIRIN THERAPY IN DIABETES

      Diabetes care
    16. COLWELL JA
      CONTROLLING TYPE-2 DIABETES - ARE THE BENEFITS WORTH THE COSTS

      JAMA, the journal of the American Medical Association
    17. COLWELL JA
      MULTIFACTORIAL ASPECTS OF THE TREATMENT OF THE TYPE-II DIABETIC PATIENT

      Metabolism, clinical and experimental
    18. COLWELL JA
      ASPIRIN THERAPY IN DIABETES-MELLITUS

      Diabetologia
    19. COLWELL JA
      PHARMACOLOGICAL STRATEGIES TO PREVENT MACROVASCULAR DISEASE IN NIDDM

      Diabetes
    20. COLWELL JA
      SHOULD WE USE INTENSIVE INSULIN THERAPY AFTER ORAL-AGENT FAILURE IN TYPE-II DIABETES

      Diabetes care
    21. COLWELL JA
      INTENSIVE INSULIN THERAPY IN TYPE-II DIABETES - RATIONALE AND COLLABORATIVE CLINICAL-TRIAL RESULTS

      Diabetes
    22. COLWELL JA
      THE FEASIBILITY OF INTENSIVE INSULIN MANAGEMENT IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - IMPLICATIONS OF THE VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN NIDDM

      Annals of internal medicine
    23. COLWELL JA; CLARK CM
      FORUM 2 - UNANSWERED RESEARCH QUESTIONS ABOUT METABOLIC CONTROL IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      Annals of internal medicine
    24. ABRAIRA C; COLWELL JA; NUTTALL FQ; SAWIN CT; NAGEL NJ; COMSTOCK JP; EMANUELE NV; LEVIN SR; HENDERSON W; LEE HS
      VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL

      Diabetes care
    25. JOKI R; KLEIN RL; LOPESVIRELLA MF; COLWELL JA
      RELEASE OF PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN WHOLE-BLOOD IS INCREASED IN PATIENTS WITH TYPE-II DIABETES

      Diabetes care
    26. JOKL R; KLEIN RL; JENKINS AJ; LOPESVIRELLA M; COLWELL JA
      ORAL VITAMIN-E SUPPLEMENTATION DOES NOT AFFECT PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI) RELEASE IN NIDDM PATIENTS

      Diabetes
    27. COLWELL JA
      NIST CHEMICAL-KINETICS DATABASE

      JOM
    28. ALTMAN R; CARRERAS L; DIAZ R; FIGUEROA E; PAOLASSO E; PARODI JC; CADE JF; DONNAN G; EADIE MJ; GAVAGHAN TP; OSULLIVAN EF; PARKIN D; RENNY JTG; SILAGY C; VINAZZER H; ZEKERT F; ADRIAENSEN H; BERTRANDHARDY JM; BRAN M; DAVID JL; DRICOT J; LAVENNEPARDONGE E; LIMET R; LOWENTHAL A; MORIAU M; SCHAPIRA S; SMETS P; SYMOENS J; VERHAEGHE R; VERSTRAETE M; ATALLAH A; BARNETT H; BATISTA R; BLAKELY J; CAIRNS JA; COTE R; CROUCH J; EVANS G; FINDLAY JM; GENT M; LANGLOIS Y; LECLERC J; NORRIS J; PINEO GF; POWERS PJ; ROBERTS R; SCHWARTZ L; SICURELLA J; TAYLOR W; THEROUX P; TURPIE AG; WEISEL RD; CUI J; LIU L; PIRK J; BAY C; BOYSEN G; KNUDSEN JB; PETERSEN P; SORENSEN PS; TONNESEN HK; HARJOLA PT; ARCAN JC; BALKAU B; BLANCHARD J; BOISSEL JP; BONEU B; BOUSSER MG; BROCHIER M; CLOAREC M; CRIBIER G; DECHAVANNE M; DROUIN P; ESCHWEGE E; GUIRAUDCHAUMEIL B; HUGONOT R; LEIZOROVICZ A; LORIA Y; MICHAT L; MIROUZE J; PANAK E; PASTEYER J; RASCOL A; REVOL L; ROY M; SELLES J; SLAMA G; STARKMAN C; TEULE M; THIBULT N; VERRY M; ALBERT FW; ANDRASSY K; BREDDIN K; ECKEL R; ENCKE A; FROHLICH J; HARTUNG B; HEISS HW; HESS H; HOFLING B; KRAUSE D; LATTA G; LINKE H; LOEW D; LORENZ R; MIDDLETON K; NOVAK G; OLDENDORF M; PFLUGER N; RAITHEL D; REUTER R; SCHETTLER G; SCHNITKER J; SCHOOP W; STIEGLER H; UBERLA K; VOGEL G; WEBER M; WELBERS I; ZEITLER E; ARAPAKIS G; CHAN T; MOK CK; SZABO R; MISRA NP; REDDY K; FITZGERALD GA; APOLLONIO A; BALSANO F; BASELLINI A; CANDELISE L; CATALANO M; CIAVARELLA N; CIUFFETTI G; COCCHERI S; CORTELLARO M; CORVI G; COTO V; DAVI G; DECATERINA R; DIPERRI T; FIESCHI C; GENTILE R; GREGORATTI L; GRESELE P; LAVEZZARI M; LIBRETTI A; MAGNANI B; NENCI G; PAGANO G; PATRONO C; PEDRINI L; PINI M; PRANDONI P; ROMEO F; ROVELLI F; RUDELLI G; RUVOLO G; SIGNORINI GP; TOGNONI G; VIOLI F; FUJIMORI T; KAGEYAMA M; KATSUMURA T; KITAMURA S; MAEDA K; SUZUKI A; TOHGI H; UCHIYAMA S; UTSUMI H; GARCIA AM; ALGRA A; DENOTTOLANDER GJH; KUPPER AJF; VANGIJN J; HART H; KAPPELLE LJ; KOUDSTAAL PJ; LEMMENS T; LODDER J; PANNEBAKKER M; SERRUYS PW; VANDENBELT A; VANDERMEER J; VANDERVIJGH AB; VERHEUGT FWA; VETH G; DALE J; JOHANNESSEN KA; THAULOW E; POPESCU P; TIBERIU N; AZNAR JRD; ESMATJES E; GUITERAS P; LASIERRA J; LOPEZTRIGO P; ORIOL A; POMAR L; ROCHA E; SANCHEZ FD; SANCHORIEGER J; SANZ G; BERGLUND ULF; BLOMSTRAND C; BOBERG M; BRITTON M; ELWIN CE; HELMERS C; HOLM J; JANZON L; JUULMOLLER S; MULEC H; OLSSON JE; PERSSON S; RASMANIS G; ROSEN A; SAMUELSSON K; SOREFF J; WAHLGREN N; WALLENTIN L; BAUR HR; BOKSLAG M; BOLLINGER A; MEIER B; PFISTERER M; PFLUGER N; SITTHIAMORN C; ACHESON EJ; APPLEBY P; ASSCHER AW; AUKLAND A; BAIGENT C; BALA S; BARNETT AH; BELL P; BEWS S; BORN GVR; BRANAGAN JP; BROOKS N; BROWN MJ; BROWSE NL; CAPILDEO R; CARMALT M; CARTER AE; CHALMERS I; CLARKE M; CLARKE RJ; CLYNE CAC; COLLINS R; COOKE ED; COUTTS G; COVE DH; CROWTHER PS; CUTHBERTSON WF; DEBONO D; DICKERSON C; DICKINSON JP; DOLL R; DORMANDY JA; DUNBABIN D; ELL S; ELPHINSTONE P; ELWOOD P; ENGLISHBY V; FARRELL B; FISKERSTRAND C; FLATHER M; FOLEY T; FOULDS T; FOX KM; FRANKS P; FRASER H; GARDECKI T; GAWEL M; GENT AE; GERSHLICK AH; GODWIN J; GOLDMAN M; GRAY C; GRAY D; GRAY R; HANDOLL H; HANKEY G; HARRISON MJG; HENDERSON N; HEPTINSTALL S; HOBBIGER SF; JONES EW; JONES NAG; JOST S; JULIAN D; KELLETT J; KESTER RC; LOWE G; MACKENZIE J; MCCOLLUM CN; MEAD G; MEADE TW; MENDELOW D; MILLER JC; MORRIS GK; NICHOL C; NOBLE M; OBRIEN JR; OGIER M; PARISH S; PARRY MJ; PETO R; POWELL J; POZZILLI P; QIZILBASH N; RAHMAN A; RAJAH SM; RICHARDS DH; RICHARDS S; RIPLEY R; ROBERTS VC; ROSE FC; RUSSELL RWR; RUBIN PC; RUCKLEY CV; SANDERCOCK P; SHAW MDM; SHAW KM; SHELLEY JH; SLATTERY J; SLEIGHT P; SMITH SJ; STEWARTLONG P; SWEETNAM PM; TANSEY MJB; TINDALL H; TURNEY J; TYLER HM; VAREY NC; VESSEY MP; WALKER MG; WALKER MA; WARLOW CP; WILCOX RG; WILLEMS H; WOOD EH; WYNJONES E; ADAMS HP; BARTON B; BEDFORD RF; BICK BL; BINGHAM S; BROWN BG; BRYANT T; BURING J; CABOT CF; CANNER P; CHESEBRO J; CHRISMAN OD; CLAGETT GP; COLWELL JA; DYKEN M; ELLIS D; FIELDS WS; FURBERG C; FUSTER V; GOLDMAN S; GRANETT J; GREEN RM; GREEN D; HARDY R; HARKER LA; HARRIS WH; HART RG; HASS WK; HENNEKENS C; HILL D; HUME M; IGLOE MC; JOHNSON G; JONAS S; KNATTERUD G; KOHLER TR; LEMBO NJ; LEWIS D; LOCKHART E; MAJERUS P; MCENANY MT; MCKENNA R; MEHTA JL; MEYER JS; MOLONY B; MORITZ T; NICOLOFF DM; NYCZ G; ONO H; PANTELY GA; PHILLIPS SJ; RIDKER P; ROBERTSON JT; ROTHBART R; SALZMAN EW; SAUTTER RD; SCHLANT RC; SCHOENBERGER JA; SENGEKONTACKET MV; SHARMA G; STEELE P; STEINNAGEL KP; STRATTON J; SULLIVAN JM; TIMMIS G; TOOLE JF; WALKER MD; WEISMAN S; WHITE CW; WIRECKI M; WOMBOLT D; WONG R; YUSUF S; ZADINA K; ZUCKER D
      COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGEDANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

      BMJ. British medical journal
    29. JOKL R; LAIMINS M; KLEIN RL; LYONS TJ; LOPESVIRELLA MF; COLWELL JA
      PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN PATIENTS WITH TYPE-II DIABETES

      Diabetes care
    30. JOKL R; COLWELL JA
      SULFONYLUREA THERAPY AND PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE IN PATIENTS WITH TYPE-2 DIABETES

      Diabetologia
    31. JOKL R; LAIMINS M; KLEIN RL; COLWELL JA
      PLATELET PAI-1 RELEASE IN PATIENTS WITH NIDDM

      Diabetes
    32. JOKL R; LAIMINS M; KLEIN RL; COLWELL JA
      PLATELET-ASSOCIATED INHIBITION OF FIBRINOLYSIS IN PATIENTS WITH NIDDM

      Diabetes
    33. ABRAIRA C; JOHNSON N; COLWELL JA
      A SUCCESSFUL FEASIBILITY TRIAL - THE VA COOPERATIVE STUDY ON CONTROL AND COMPLICATIONS IN DIABETES-MELLITUS TYPE-II (CSDM)

      Diabetes


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 14:41:09